4-hydroxy-6-[(2S,4R,5E,7S,8R,9E)-2,4,8-trihydroxy-7,9-dimethylundeca-5,9-dienyl]pyran-2-one

Details

Top
Internal ID 09686ace-742a-4b56-aeda-b62879595051
Taxonomy Lipids and lipid-like molecules > Fatty Acyls > Fatty alcohols
IUPAC Name 4-hydroxy-6-[(2S,4R,5E,7S,8R,9E)-2,4,8-trihydroxy-7,9-dimethylundeca-5,9-dienyl]pyran-2-one
SMILES (Canonical)
SMILES (Isomeric)
InChI InChI=1S/C18H26O6/c1-4-11(2)18(23)12(3)5-6-13(19)7-14(20)8-16-9-15(21)10-17(22)24-16/h4-6,9-10,12-14,18-21,23H,7-8H2,1-3H3/b6-5+,11-4+/t12-,13-,14-,18-/m0/s1
InChI Key OPFJLTUTGMXQDY-VHPQGISRSA-N
Popularity 2 references in papers

Physical and Chemical Properties

Top
Molecular Formula C18H26O6
Molecular Weight 338.40 g/mol
Exact Mass 338.17293854 g/mol
Topological Polar Surface Area (TPSA) 107.00 Ų
XlogP 1.50
Atomic LogP (AlogP) 1.52
H-Bond Acceptor 6
H-Bond Donor 4
Rotatable Bonds 8

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of 4-hydroxy-6-[(2S,4R,5E,7S,8R,9E)-2,4,8-trihydroxy-7,9-dimethylundeca-5,9-dienyl]pyran-2-one

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.8616 86.16%
Caco-2 - 0.6402 64.02%
Blood Brain Barrier - 0.6250 62.50%
Human oral bioavailability - 0.7286 72.86%
Subcellular localzation Mitochondria 0.6882 68.82%
OATP2B1 inhibitior - 0.8600 86.00%
OATP1B1 inhibitior + 0.7794 77.94%
OATP1B3 inhibitior + 0.9639 96.39%
MATE1 inhibitior - 0.7600 76.00%
OCT2 inhibitior - 0.9250 92.50%
BSEP inhibitior - 0.5914 59.14%
P-glycoprotein inhibitior - 0.8604 86.04%
P-glycoprotein substrate - 0.7457 74.57%
CYP3A4 substrate + 0.5000 50.00%
CYP2C9 substrate + 0.6593 65.93%
CYP2D6 substrate - 0.8579 85.79%
CYP3A4 inhibition + 0.6079 60.79%
CYP2C9 inhibition - 0.7978 79.78%
CYP2C19 inhibition - 0.6041 60.41%
CYP2D6 inhibition - 0.8725 87.25%
CYP1A2 inhibition - 0.8708 87.08%
CYP2C8 inhibition - 0.6793 67.93%
CYP inhibitory promiscuity - 0.6064 60.64%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.8583 85.83%
Carcinogenicity (trinary) Non-required 0.5010 50.10%
Eye corrosion - 0.9712 97.12%
Eye irritation - 0.9780 97.80%
Skin irritation - 0.5823 58.23%
Skin corrosion - 0.9206 92.06%
Ames mutagenesis - 0.7000 70.00%
Human Ether-a-go-go-Related Gene inhibition - 0.5877 58.77%
Micronuclear + 0.5818 58.18%
Hepatotoxicity + 0.6250 62.50%
skin sensitisation - 0.6374 63.74%
Respiratory toxicity + 0.6333 63.33%
Reproductive toxicity + 0.6111 61.11%
Mitochondrial toxicity - 0.5625 56.25%
Nephrotoxicity - 0.6829 68.29%
Acute Oral Toxicity (c) III 0.5654 56.54%
Estrogen receptor binding + 0.7346 73.46%
Androgen receptor binding + 0.6629 66.29%
Thyroid receptor binding - 0.5057 50.57%
Glucocorticoid receptor binding + 0.6768 67.68%
Aromatase binding + 0.5488 54.88%
PPAR gamma + 0.6498 64.98%
Honey bee toxicity - 0.8419 84.19%
Biodegradation - 0.8750 87.50%
Crustacea aquatic toxicity - 0.7227 72.27%
Fish aquatic toxicity + 0.7031 70.31%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.91% 91.11%
CHEMBL2581 P07339 Cathepsin D 98.38% 98.95%
CHEMBL3401 O75469 Pregnane X receptor 95.60% 94.73%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 94.97% 85.14%
CHEMBL1293249 Q13887 Kruppel-like factor 5 89.10% 86.33%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 88.98% 95.56%
CHEMBL3060 Q9Y345 Glycine transporter 2 85.60% 99.17%
CHEMBL5845 P23415 Glycine receptor subunit alpha-1 82.57% 90.71%
CHEMBL1806 P11388 DNA topoisomerase II alpha 81.95% 89.00%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 81.57% 94.45%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
There are no matching plants.

Cross-Links

Top
PubChem 163194222
LOTUS LTS0043213
wikiData Q105196037